Clinical Trials Directory

Trials / Unknown

UnknownNCT04808674

Remediation for Mild Cognitive Deficits After Cancer

EvalUation of REmediation Programs for Patients Suffering From Mild Cognitive Deficits After CAncer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Cancer survival rates have improved significantly over the past decades and patients now experience a number of side effects including cancer-related cognitive impairment (CRCI): problems with memory, executive function, attention, and difficulties performing two tasks at the same time. The frequency of CRCI in cancer patients is estimated to be between 10 to 40%, and more than 50% of patients describe difficulties in their daily life. These cognitive difficulties negatively impact the patient's quality of life as well as that of their family, and can also have negative consequences for their social and professional reintegration once cancer treatment is finished. Despite an increasing number of studies on CRCI, a standard of care for patients with CRCI after breast cancer is yet to be established. In the absence of clear directives, and in an attempt to respond to the increasing demand to provide care for breast cancer patients with CRCI, physical medicine and rehabilitation units in France have started providing day-hospital multidisciplinary interventions. The objective of this project is to use the single case experimental design method to investigate the efficacy of two such rehabilitation programs: a group-based program and a one-on-one program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive remediation programEvaluation of REmediation programs for patients suffering from mild cognitive deficits after Cancer

Timeline

Start date
2021-12-17
Primary completion
2025-07-17
Completion
2025-07-17
First posted
2021-03-22
Last updated
2023-01-13

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04808674. Inclusion in this directory is not an endorsement.